John M. Hamm - Net Worth and Insider Trading

John M. Hamm Net Worth

The estimated net worth of John M. Hamm is at least $8,092 dollars as of 2024-11-11. John M. Hamm is the CFO of Cumberland Pharmaceuticals Inc and owns about 6,800 shares of Cumberland Pharmaceuticals Inc (CPIX) stock worth over $8,092. Details can be seen in John M. Hamm's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John M. Hamm has not made any transactions after 2021-11-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of John M. Hamm

To

John M. Hamm Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John M. Hamm owns 1 companies in total, including Cumberland Pharmaceuticals Inc (CPIX) .

Click here to see the complete history of John M. Hamm’s form 4 insider trades.

Insider Ownership Summary of John M. Hamm

Ticker Comapny Transaction Date Type of Owner
CPIX Cumberland Pharmaceuticals Inc 2021-11-23 Chief Financial Officer

John M. Hamm Latest Holdings Summary

John M. Hamm currently owns a total of 1 stock. John M. Hamm owns 6,800 shares of Cumberland Pharmaceuticals Inc (CPIX) as of November 23, 2021, with a value of $8,092.

Latest Holdings of John M. Hamm

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CPIX Cumberland Pharmaceuticals Inc 2021-11-23 6,800 1.19 8,092

Holding Weightings of John M. Hamm


John M. Hamm Form 4 Trading Tracker

According to the SEC Form 4 filings, John M. Hamm has made a total of 1 transactions in Cumberland Pharmaceuticals Inc (CPIX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cumberland Pharmaceuticals Inc is the acquisition of 3,800 shares on November 23, 2021, which cost John M. Hamm around $8,930.

Insider Trading History of John M. Hamm

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John M. Hamm Trading Performance

GuruFocus tracks the stock performance after each of John M. Hamm's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John M. Hamm is 30.6%. GuruFocus also compares John M. Hamm's trading performance to market benchmark return within the same time period. The performance of stocks bought by John M. Hamm within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John M. Hamm's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John M. Hamm

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 120.69 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 119.94 LIMIT LIMIT LIMIT LIMIT LIMIT

John M. Hamm Ownership Network

Ownership Network List of John M. Hamm

No Data

Ownership Network Relation of John M. Hamm

Insider Network Chart

John M. Hamm Owned Company Details

What does Cumberland Pharmaceuticals Inc do?

Who are the key executives at Cumberland Pharmaceuticals Inc?

John M. Hamm is the Chief Financial Officer of Cumberland Pharmaceuticals Inc. Other key executives at Cumberland Pharmaceuticals Inc include director & 10 percent owner & Chairman and CEO A J Kazimi , Vice Pres Sales & Marketing Chris T. Bitterman , and Vice Pres Organizational Dev Todd M. Anthony .

Cumberland Pharmaceuticals Inc (CPIX) Insider Trades Summary

Over the past 18 months, John M. Hamm made no insider transaction in Cumberland Pharmaceuticals Inc (CPIX). Other recent insider transactions involving Cumberland Pharmaceuticals Inc (CPIX) include a net purchase of 7,107 shares made by Kenneth Krogulski , a net purchase of 1,426 shares made by James Jones , and a net purchase of 1,426 shares made by A J Kazimi .

In summary, during the past 3 months, insiders sold 0 shares of Cumberland Pharmaceuticals Inc (CPIX) in total and bought 10,672 shares, with a net purchase of 10,672 shares. During the past 18 months, 0 shares of Cumberland Pharmaceuticals Inc (CPIX) were sold and 10,672 shares were bought by its insiders, resulting in a net purchase of 10,672 shares.

Cumberland Pharmaceuticals Inc (CPIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cumberland Pharmaceuticals Inc Insider Transactions

No Available Data

John M. Hamm Mailing Address

Above is the net worth, insider trading, and ownership report for John M. Hamm. You might contact John M. Hamm via mailing address: 2525 West End Avenue, Suite 950, Nashville Tn 37203.